key: cord-0905974-0ptstyau
authors: Kao, Chia-Lung; Hong, Ming-Yuan; Chi, Chih-Hsien
title: Cover the Patients’ Mouths While Obtaining Nasopharyngeal Specimens
date: 2020-12-19
journal: Ann Emerg Med
DOI: 10.1016/j.annemergmed.2020.08.031
sha: 7e3af1781314ac0b20ccb5de6bf1492466a7530c
doc_id: 905974
cord_uid: 0ptstyau

nan

Data were collected from July to August 2019 with the use of a self-administered, online survey sent to a subset of treatment-seeking opioid users sampled from a larger, more extensive national opioid surveillance system that collects data from new entrants to 1 of 100 treatment centers for opioid use disorder across the United States. 4 Of 781 opioid users who previously sought treatment and were sent the online survey, 296 respondents from 46 states answered questions about their opioid use before entering treatment as it related to naloxone, listed as "naloxone (Narcan)" to account for familiarity with either one of these commonly used terms.

As shown in the Table, 75.0% of treatment-seeking opioid users indicated no change in their likelihood of using opioids if they believed or knew naloxone would be used to revive them if they were to overdose. Similarly, 88.5% of respondents indicated they did not change their opioid use behaviors (ie, use opioids more often or in greater quantities) when they believed or knew naloxone would be used to revive them if they overdosed. A total of 63.5% of individuals were slightly to completely confident a first responder would have naloxone to revive them if they overdosed, with only 32.4% having any confidence that someone they knew would have and knew how to use naloxone.

These data suggest that even if long-term opioid users believe or know that naloxone would be available to revive them if they overdose, opioid use patterns and behaviors do not change as a result. This runs counter to stigmatizing claims that the use of naloxone as a harm-reduction strategy encourages or increases the reckless use of opioids. Thus, as a public health measure, the magnitude of naloxone's lifesaving potential appears to outweigh any potential increases in opioid consumption that may occur either in perception or reality. As such, naloxone education and training among first responders and community members should focus on reducing negative perceptions both of naloxone and of substance use in general. Destigmatization of naloxone and addiction is particularly relevant in light of the lethality of an increasing number of fentanyl analogues and renewed increases in opioid overdoses the United States has experienced in recent months. 5 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. 

To the Editor:

To diagnose airborne infectious diseases such as coronavirus disease 2019 (COVID-19) or influenza, health care workers often need to collect respiratory specimens. The most common methods for respiratory specimen collections for severe acute respiratory syndrome coronavirus 2 and other airborne infectious pathogens include nasopharyngeal and oropharyngeal swabs or wash in ambulatory patients and lower respiratory specimens in patients with more severe respiratory disease. 1 The upper respiratory specimens are more widely used than lower ones. All of these aerosolgenerating procedures may increase the chance for health care workers to be infected. 2 In previous studies, nasopharyngeal swab showed a higher positive rate than oropharyngeal swab and may be more applicable at this stage of the COVID-19 outbreak. 3 In the COVID-19 pandemic, obtaining a nasopharyngeal swab specimen is common for patients with suspected COVID-19. Numerous photographs and videos demonstrating the procedure can be seen in both public social media and academic texts, including journals. However, under such a procedure, the patient whom the operator is facing is often depicted as having the mask taken off, which increases the risk of transmitting infective droplets or aerosols to the operator.

Additionally, the insertion of a nasopharyngeal swab may trigger cough, gagging, or vomiting, generating even larger amounts of droplets or aerosols and thus increasing the risk of cross infection.

Strategies should be adopted to provide safer conditions for health care workers during the collection of nasopharyngeal swab samples. We emphasize and remind that the patient's mouth should be covered with a mask during the collecting process. The patient is therefore required to pull down the mask to show only the nostrils while the mouth remains fully covered by the mask (Figure) . The benefit of this act is supported by the study, which demonstrates that covering the mouth with a cloth results in a decrease in the production of oral fluid droplets. 4 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. Figure. Obtaining the nasopharyngeal swab specimen for a patient wearing a mask. During collection of the specimen, the patient is required to pull down the mask to show only the nostrils while the mouth remains fully covered by the mask. By doing so, infective droplets or aerosols from the patient's mouth are effectively reduced.

World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance

Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium

Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously

Images in clinical medicine. Coughing and masks